Trademark: 97539845
Word
ELSIE BIOTECHNOLOGIES
Status Date
Monday, August 5, 2024
Filing Date
Monday, August 8, 2022
Published for Opposition
Tuesday, December 19, 2023
40 Custom manufacture of oligonucleotides
5 Oligonucleotide compounds for use as pharmaceutical therapies prescribed or administered by a physician for the treatment of a wide variety of conditions and illnesses; Oligonucleotide delivery agents that facilitate delivery of a wide range of pharmaceutical therapies prescribed or administered by a physician; Oligonucleotide-based or -derived pharmaceuticals prescribed or administered by a physician for the treatment of a wide variety of conditions and illnesses; Pharmaceuticals prescribed or administered by a physician comprised of oligonucleotide compounds for the treatment of a wide variety of conditions and illnesses; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents prescribed or administered by a physician; drug delivery agents consisting of oligonucleotide compounds that facilitate delivery of a wide range of pharmaceuticals prescribed or administered by a physician
1 Oligonucleotide compounds for use in the manufacture of pharmaceutical therapies
42 Research and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds
May 24, 2023
Assigned To Examiner
Aug 11, 2022
New Application Entered
Aug 29, 2022
New Application Office Supplied Data Entered
Jun 29, 2023
Non-Final Action Written
Jun 29, 2023
Non-Final Action E-Mailed
Jun 29, 2023
Notification Of Non-Final Action E-Mailed
Sep 27, 2023
Teas Response To Office Action Received
Sep 27, 2023
Correspondence Received In Law Office
Sep 27, 2023
Teas/Email Correspondence Entered
Nov 29, 2023
Notification Of Notice Of Publication E-Mailed
Nov 13, 2023
Approved For Pub - Principal Register
Dec 19, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 19, 2023
Published For Opposition
Aug 5, 2024
Sou Teas Extension Received
Aug 5, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2024
Sou Extension 1 Filed
Aug 5, 2024
Sou Extension 1 Granted
Feb 13, 2024
Noa E-Mailed - Sou Required From Applicant
Trademark Alertz updated from USPTO on 2030-01-24
